Publications in collaboration with researchers from Hospital Universitari de Bellvitge (2)

2025

  1. Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

    Experimental Hematology and Oncology, Vol. 14, Núm. 1

2024

  1. Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study

    Leukemia, Vol. 38, Núm. 10, pp. 2259-2265